- Home
- Free App Analytics
- SARCULATOR
- SARCULATOR Vs. Rad Onc Tables
SARCULATOR vs Rad Onc Tables Usage & Stats
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
- Apple App Store
- Free
- Medical
Store Rank
- -
A quick reference tool for finding, summarizing, and linking directly to research related to radiation oncology.
- Apple App Store
- Free
- Medical
Store Rank
- -
SARCULATOR vs. Rad Onc Tables ranking comparison
Compare SARCULATOR ranking trend in the past 28 days vs. Rad Onc Tables
Rank
No Data Available
SARCULATOR vs. Rad Onc Tables ranking by country comparison
Compare SARCULATOR ranking trend in the past 28 days vs. Rad Onc Tables
No Data to Display
Compare to any site with our free trial
SARCULATOR VS.
Rad Onc Tables
January 8, 2025